Serial Number
98597164
Owner
Orbital Therapeutics, Inc.Attorney
Marilyn F. KellyFiling Date
Jun 12, 2024
ORBITAL THERAPEUTICS Trademark
Serial Number: 98597164
Trademark Classes
Owner Contact Info
100 Binney Street, Floor 4
Cambridge, MA 02142
Entity Type: 03
Legal Representation
Correspondence Address
Marilyn F. Kelly Bristol-Myers Squibb Company
P.O. Box 4000
Trademark Dept., Mailstop D. 4243
Princeton, NJ 08548-4000
United States
Trademark Details
Filing Date
June 12, 2024
Registration Date
Not Registered
Published for Opposition
March 11, 2025
Goods & Services
Research and development in the biotechnology field; Consulting services in the fields of biotechnology and genetic science; Development of new technology for others in the fields of genomics and biotechnology; Providing laboratory research services in the field of gene expression or RNA-based therapeutics; Testing, inspection, research, or development of chemical and biotechnology preparations; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids
Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Pharmaceutical preparations in the nature of protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Therapeutic and preventative vaccines; Medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; RNA-based therapeutics for the treatment and prevention of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; Therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders